Summary
This article reports the powerful therapeutic benefits of manuka honey due to its unique antibacterial activity, and its growing demand in the global market. Manuka honey is primarily produced in New Zealand, and its unique methylglyoxal component endows it with outstanding antibacterial, anti-inflammatory, and antioxidant properties. Research shows that manuka honey is effective in wound healing, soothing sore throats, and boosting immunity.
With consumers favouring natural health products, the market prospects for manuka honey are very promising, especially in regions such as China, the US, and Europe where demand is strong. As the main producer, New Zealand's manuka honey industry is experiencing rapid growth, but also faces challenges such as widespread counterfeit products and sustainable production.
Commentary
For New Zealand small and medium-sized enterprise (SME) owners, the continued heating up of the manuka honey market is both an opportunity and a test. On one hand, rising global health awareness is driving demand for natural products; high-end manuka honey (e.g., UMF 15+) has strong pricing power and substantial profit margins. Chinese consumers particularly value origin and certification; businesses can enhance value-added by strengthening the New Zealand origin brand and obtaining UMF certification.
On the other hand, there are signs of supply glut, and SMEs need to be wary of the risk of price wars. Meanwhile, counterfeit products may damage industry reputation; businesses should invest in anti-counterfeiting technology and build direct customer relationships. Additionally, climate change affects nectar sources; it is advisable to consider diversified planting to spread risk.
In the long term, the manuka honey market will continue to grow, but SMEs need to focus on niche markets (e.g., medical-grade honey, skincare ingredients) or explore emerging channels (e.g., cross-border e-commerce) rather than relying solely on bulk exports.
Keywords: manuka honey, therapeutic benefits, market prospects, New Zealand, UMF certification, antibacterial activity, natural health products, export opportunities, counterfeit products, sustainable production
Summary in Chinese | 摘要
本文报道了麦卢卡蜂蜜因其独特的抗菌活性而具有强大的治疗功效，以及在全球市场上日益增长的需求。麦卢卡蜂蜜主要产自新西兰，其独特的甲基乙二醛成分赋予其卓越的抗菌、抗炎和抗氧化特性。研究表明，麦卢卡蜂蜜在伤口愈合、缓解喉咙痛和增强免疫力方面效果显著。
随着消费者对天然健康产品的青睐，麦卢卡蜂蜜的市场前景十分广阔，尤其在中国、美国和欧洲等地区需求旺盛。新西兰作为主要产地，其麦卢卡蜂蜜产业正迎来快速发展期，但也面临假冒产品泛滥和可持续生产等挑战。
Commentary in Chinese | 评论
对于新西兰中小企业主而言，麦卢卡蜂蜜市场的持续升温既是机遇也是考验。一方面，全球健康意识提升带动天然产品需求，高端麦卢卡蜂蜜（如UMF 15+）定价能力强，利润空间可观。中国消费者尤其看重产地和认证，企业可通过强化新西兰原产地品牌、获取UMF认证来提升附加值。
另一方面，市场已出现供应过剩迹象，中小企业需警惕价格战风险。同时，假冒产品问题可能损害行业信誉，企业应投资防伪技术并建立直接客户关系。此外，气候变化影响蜜源植物，建议关注多样化种植以分散风险。
从长期看，麦卢卡蜂蜜市场仍保持增长，但中小企业需聚焦细分市场（如医疗级蜂蜜、护肤品原料）或拓展新兴渠道（如跨境电商），而非单纯依赖大宗出口。
关键词: 麦卢卡蜂蜜, 治疗功效, 市场前景, 新西兰, UMF认证, 抗菌活性, 天然健康产品, 出口机遇, 假冒产品, 可持续生产
Source: NetEase
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
免责声明：本文基于公开信息编译，仅供一般性参考。文中分析与评论为编辑观点。MiDeer Observer 不对所提供信息的准确性或完整性作出保证。读者在依赖本文内容前，应寻求独立专业意见，或联系我们获取更多信息。